Compare TWI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWI | ORGO |
|---|---|---|
| Founded | 1890 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 518.0M | 514.0M |
| IPO Year | 1993 | N/A |
| Metric | TWI | ORGO |
|---|---|---|
| Price | $11.06 | $3.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $11.50 | $8.00 |
| AVG Volume (30 Days) | 582.8K | ★ 669.1K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,801,577,000.00 | $465,218,000.00 |
| Revenue This Year | N/A | $8.14 |
| Revenue Next Year | $4.04 | $6.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.24 |
| 52 Week Low | $5.93 | $2.61 |
| 52 Week High | $10.94 | $7.08 |
| Indicator | TWI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 72.66 | 39.14 |
| Support Level | $8.55 | $3.70 |
| Resistance Level | $10.94 | $4.38 |
| Average True Range (ATR) | 0.41 | 0.19 |
| MACD | 0.16 | 0.02 |
| Stochastic Oscillator | 89.12 | 26.28 |
Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.